| ASSET | QUARTER | % RETURN |
|---|---|---|
Celsius (CELH) | Q1 2015 | 149.97% |
Neurocrine Biosciences (NBIX) | Q1 2015 | 75.79% |
Exelixis (EXEL) | Q1 2015 | 74.83% |
Wayfair (W) | Q1 2015 | 60.68% |
Stellantis (STLA) | Q1 2015 | 40.72% |
CyberArk Software (CYBR) | Q1 2015 | 39.69% |
Kraft Heinz (KHC) | Q1 2015 | 38.87% |
ICON (ICLR) | Q1 2015 | 38.21% |
Coherent (COHR) | Q1 2015 | 34.16% |
First Solar (FSLR) | Q1 2015 | 33.7% |
Boston Scientific (BSX) | Q1 2015 | 33.56% |
United Therapeutics (UTHR) | Q1 2015 | 33.15% |
Centene (CNC) | Q1 2015 | 32.98% |
Insmed (INSM) | Q1 2015 | 32.82% |
NXP Semiconductors (NXPI) | Q1 2015 | 31.09% |
Sony (SONY) | Q1 2015 | 30.82% |
Advanced Drainage Systems (WMS) | Q1 2015 | 30.54% |
Valero Energy (VLO) | Q1 2015 | 29.34% |
MSCI (MSCI) | Q1 2015 | 28.96% |
EPAM Systems (EPAM) | Q1 2015 | 28.3% |
Diamondback Energy (FANG) | Q1 2015 | 27.96% |
ResMed (RMD) | Q1 2015 | 27.84% |
Coca-Cola Consolidated (COKE) | Q1 2015 | 27.64% |
Smurfit WestRock (SW) | Q1 2015 | 27.58% |
Novo Nordisk A-S (NVO) | Q1 2015 | 27.44% |
Large-cap stocks are treated as having a market cap of $10B+.
